Literature DB >> 3088214

Neurofibromatosis xenografts. Contribution to pathogenesis.

O Appenzeller, M Kornfeld, R Atkinson, R D Snyder.   

Abstract

We transplanted Schwann cells of 3 patients with neurofibromatosis from neurofibromas, sural nerve, and from a malignant schwannoma into sciatic nerves of immunoincompetent mice. Three and six months later, the grafts and distal nerve segments contained normal myelinated fibers. After rendering host animals immune competent again, neurofibroma and malignant schwannoma Schwann cells were rejected, but grafts retained normally myelinated fibers indicating that these were of mouse origin. Sural nerve Schwann cells from a neurofibromatosis patient were rejected also leaving naked axons in the grafted segments showing that human Schwann cells from the sural nerve of one patient had invested and myelinated the regenerating mouse axons. The nature of putative signals passing between axons and Schwann cells might be elucidated by the combination of human and animal cells in immunoincompetent host nerves. Hypothetical signals for myelination of mouse axons were normally received by sural nerve Schwann cells of a patient with neurofibromatosis, but not by Schwann cells from neurofibromas or malignant schwannomas.

Entities:  

Mesh:

Year:  1986        PMID: 3088214     DOI: 10.1016/0022-510x(86)90192-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.

Authors:  D Muir; D Neubauer; I T Lim; A T Yachnis; M R Wallace
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse.

Authors:  J K Lee; R A Sobel; E A Chiocca; T S Kim; R L Martuza
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

3.  Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.

Authors:  Dusica Babovic-Vuksanovic; Lydia Petrovic; Bruce E. Knudsen; Timothy B. Plummer; Joseph E. Parisi; Srdan Babovic; Jeffrey L. Platt
Journal:  J Biomed Biotechnol       Date:  2004
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.